AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. Pharmarise Holdings Corporation
  3. Financials
  4. EBITDA margin (%)

Pharmarise Holdings Corporation【JP:2796】

Market cap
¥6.2B
P/E ratio
21.8x
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndEBITDA margin (%) YoY (%)
May 31, 20251.6-42.62%
May 31, 20242.8-27.94%
May 31, 20233.9-5.52%
May 31, 20224.1+16.50%
May 31, 20213.5+16.08%
May 31, 20203+34.70%
May 31, 20192.3-31.57%
May 31, 20183.3+62.34%
May 31, 20172-29.43%
May 31, 20162.9-32.38%
May 31, 20154.3-20.75%
May 31, 20145.4

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)